Pacific Edge Limited
PFGTF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$138.06M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $138.06 Million |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $-0.04 |
| Beta | 0.82 |
| Outstanding Shares | 1,022,631,578 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -6.14 |
|---|---|
| PEG | -67.83 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Next Earnings Call
Expected Date
November 19, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Pacific Edge Limited
114 employees
CEO: Peter Meintjes
Pacific Edge Limited, a cancer diagnostics firm headquartered in Dunedin, New Zealand, and established in 2001, is dedicated to the research, development, and commercialization of advanced diagnostic and prognostic tools. These innovatio...